• Home
  • Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.

Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.

Author List
Moll T, Odon V, Harvey C, Collins MO, Peden A, Franklin J, Graves E, Marshall JN, Dos Santos Souza C, Zhang S, Castelli L, Hautbergue G, Azzouz M, Gordon D, Krogan N, Ferraiuolo L, Snyder MP, Shaw PJ, Rehwinkel J, Cooper-Knock J
Publication
Life science alliance
Publication ID (Profile URL)
https://researcherprofiles.org/profile/339111236
Publication Year
2022
PubMed ID
36241425
Publication Title
Moll T, Odon V, Harvey C, Collins MO, Peden A, Franklin J, Graves E, Marshall JN, Dos Santos Souza C, Zhang S, Castelli L, Hautbergue G, Azzouz M, Gordon D, Krogan N, Ferraiuolo L, Snyder MP, Shaw PJ, Rehwinkel J, Cooper-Knock J. Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication. Life Sci Alliance. 2023 01; 6(1).